Abdulqadir Nashwan is a Director of Nursing for Education and Practice Development at HMGH a member of Hamad Medical Corporation (HMC) in Qatar. In 2015, he has been appointed as a Senior Adjunct Instructor at the faculty of nursing at the University of Calgary in Qatar (UCQ). His current research interests include Research Utilization, Evidenced-Based Practice, Clinical Hematology, Medical Oncology, Nursing Informatics, and Cancer Immunotherapy. Mr. Nashwan has published more than 50 research articles in peer-reviewed journals such as the Blood, BMJ, and Journal of Pediatric Oncology Nursing. In November 2015, he has received Award of Merit for Placing HMC at the Cutting Edge of Cancer Research as a part of Stars of Excellence Program introduced by HMC. In October 2016, Mr. Nashwan has completed a Cancer Biology & Therapeutics (CBT) Program; provided by Harvard Medical School (HMS). Mr. Nashwan has been committed to mentoring and encouraging young clinical investigators throughout his career; he has formally supervised the training of more than a dozen MSc candidates and nursing fellows. His expertise is routinely sought in an advisory capacity both nationally and internationally; he has served as a member of health policy subgroup at ICN Nurse Practitioner/Advance Practice Nursing Network (APNN), also he has served a reviewer for several reputable journals (e.g., Journal of Applied Nursing Research, Asia-Pacific Journal of Oncology Nursing, and Journal of Cancer Therapy) and as an editorial board member at the International Journal of Nursing & Hospital Care and Trends in Medicine & Health (TMH).
His current research interests include Research Utilization, Evidenced-Based Practice, Clinical Hematology, Medical Oncology, Nursing Informatics, and Cancer Immunotherapy